Literature DB >> 16075047

Akt1 in the cardiovascular system: friend or foe?

Brian T O'Neill1, E Dale Abel.   

Abstract

Akt is an important signaling molecule that modulates many cellular processes such as cell growth, survival, and metabolism. Akt activation has been proposed as a potential strategy for increasing cardiomyocyte survival following ischemia. In mammalian cells, 3 distinct isoforms of Akt exist, but their precise roles in cardiovascular biology were previously unknown. Three separate studies published in this issue of the JCI now provide important new insight into the central role of Akt1 in the regulation of angiogenesis and the maladaptive or deleterious consequences of chronic unregulated Akt activation in the heart (see the related articles beginning on pages 2108, 2119, and 2128). Here we discuss the implications of these exciting new studies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16075047      PMCID: PMC1180557          DOI: 10.1172/JCI25900

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  The conserved phosphoinositide 3-kinase pathway determines heart size in mice.

Authors:  T Shioi; P M Kang; P S Douglas; J Hampe; C M Yballe; J Lawitts; L C Cantley; S Izumo
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

2.  The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110alpha) pathway.

Authors:  Julie R McMullen; Tetsuo Shioi; Weei-Yuarn Huang; Li Zhang; Oleg Tarnavski; Egbert Bisping; Martina Schinke; Sekwon Kong; Megan C Sherwood; Jeffrey Brown; Lauren Riggi; Peter M Kang; Seigo Izumo
Journal:  J Biol Chem       Date:  2003-11-03       Impact factor: 5.157

3.  Mechanism of enhanced cardiac function in mice with hypertrophy induced by overexpressed Akt.

Authors:  Young-Kwon Kim; Song-Jung Kim; Atsuko Yatani; Yanhong Huang; Germana Castelli; Dorothy E Vatner; Jing Liu; Qizhi Zhang; Gissela Diaz; Renata Zieba; Jill Thaisz; Alessandra Drusco; Carlo Croce; Junichi Sadoshima; Gianluigi Condorelli; Stephen F Vatner
Journal:  J Biol Chem       Date:  2003-09-16       Impact factor: 5.157

4.  Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts.

Authors:  Abeel A Mangi; Nicolas Noiseux; Deling Kong; Huamei He; Mojgan Rezvani; Joanne S Ingwall; Victor J Dzau
Journal:  Nat Med       Date:  2003-08-10       Impact factor: 53.440

Review 5.  The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease.

Authors:  Gavin Y Oudit; Hui Sun; Benoit-Gilles Kerfant; Michael A Crackower; Josef M Penninger; Peter H Backx
Journal:  J Mol Cell Cardiol       Date:  2004-08       Impact factor: 5.000

6.  Phosphoinositide 3-kinase(p110alpha) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy.

Authors:  Julie R McMullen; Tetsuo Shioi; Li Zhang; Oleg Tarnavski; Megan C Sherwood; Peter M Kang; Seigo Izumo
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-24       Impact factor: 11.205

7.  Deletion of ribosomal S6 kinases does not attenuate pathological, physiological, or insulin-like growth factor 1 receptor-phosphoinositide 3-kinase-induced cardiac hypertrophy.

Authors:  Julie R McMullen; Tetsuo Shioi; Li Zhang; Oleg Tarnavski; Megan C Sherwood; Adam L Dorfman; Sarah Longnus; Mario Pende; Kathleen A Martin; John Blenis; George Thomas; Seigo Izumo
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

8.  Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload.

Authors:  Julie R McMullen; Megan C Sherwood; Oleg Tarnavski; Li Zhang; Adam L Dorfman; Tetsuo Shioi; Seigo Izumo
Journal:  Circulation       Date:  2004-06-07       Impact factor: 29.690

Review 9.  A portrait of AKT kinases: human cancer and animal models depict a family with strong individualities.

Authors:  Alfonso Bellacosa; Joseph R Testa; Robert Moore; Lionel Larue
Journal:  Cancer Biol Ther       Date:  2004-03-11       Impact factor: 4.742

10.  Deficiency of PDK1 in cardiac muscle results in heart failure and increased sensitivity to hypoxia.

Authors:  Alfonso Mora; Anthony M Davies; Luc Bertrand; Isam Sharif; Grant R Budas; Sofija Jovanović; Véronique Mouton; C Ronald Kahn; John M Lucocq; Gillian A Gray; Aleksandar Jovanović; Dario R Alessi
Journal:  EMBO J       Date:  2003-09-15       Impact factor: 11.598

View more
  49 in total

1.  Co-activation of nuclear factor-κB and myocardin/serum response factor conveys the hypertrophy signal of high insulin levels in cardiac myoblasts.

Authors:  Rosalinda Madonna; Yong-Jian Geng; Roberto Bolli; Gregg Rokosh; Peter Ferdinandy; Cam Patterson; Raffaele De Caterina
Journal:  J Biol Chem       Date:  2014-05-22       Impact factor: 5.157

2.  Activation of extracellular signal-regulated kinase 5 reduces cardiac apoptosis and dysfunction via inhibition of a phosphodiesterase 3A/inducible cAMP early repressor feedback loop.

Authors:  Chen Yan; Bo Ding; Tetsuro Shishido; Chang-Hoon Woo; Seigo Itoh; Kye-Im Jeon; Weimin Liu; Haodong Xu; Carolyn McClain; Carlos A Molina; Burns C Blaxall; Jun-ichi Abe
Journal:  Circ Res       Date:  2007-02-01       Impact factor: 17.367

3.  Akt1 is necessary for the vascular maturation and angiogenesis during cutaneous wound healing.

Authors:  Payaningal R Somanath; Juhua Chen; Tatiana V Byzova
Journal:  Angiogenesis       Date:  2008-04-16       Impact factor: 9.596

Review 4.  Cardiac adaptation to exercise training in health and disease.

Authors:  Dae Yun Seo; Hyo-Bum Kwak; Amy Hyein Kim; Se Hwan Park; Jun Won Heo; Hyoung Kyu Kim; Jeong Rim Ko; Sam Jun Lee; Hyun Seok Bang; Jun Woo Sim; Min Kim; Jin Han
Journal:  Pflugers Arch       Date:  2019-04-23       Impact factor: 3.657

5.  Phosphoinositide dependent protein kinase 1 is required for exercise-induced cardiac hypertrophy but not the associated mitochondrial adaptations.

Authors:  Junghyun Noh; Adam R Wende; Curtis D Olsen; Bumjun Kim; Jack Bevins; Yi Zhu; Quan-Jiang Zhang; Christian Riehle; E Dale Abel
Journal:  J Mol Cell Cardiol       Date:  2015-10-22       Impact factor: 5.000

6.  Differential role of PI3K/Akt pathway in the infarct size limitation and antiarrhythmic protection in the rat heart.

Authors:  Tána Ravingerová; Jana Matejíková; Jan Neckár; Eva Andelová; Frantisek Kolár
Journal:  Mol Cell Biochem       Date:  2006-10-03       Impact factor: 3.396

7.  Akt1 genetic deficiency limits hypothermia cardioprotection following murine cardiac arrest.

Authors:  David G Beiser; Kimberly R Wojcik; Danhong Zhao; Gerasim A Orbelyan; Kimm J Hamann; Terry L Vanden Hoek
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-02       Impact factor: 4.733

8.  Sympathetic activation causes focal adhesion signaling alteration in early compensated volume overload attributable to isolated mitral regurgitation in the dog.

Authors:  Abdelkarim Sabri; Khadija Rafiq; Rachid Seqqat; Mikhail A Kolpakov; Ray Dillon; Louis J Dell'italia
Journal:  Circ Res       Date:  2008-03-20       Impact factor: 17.367

9.  Protective role of PI3-kinase-Akt-eNOS signalling pathway in intestinal injury associated with splanchnic artery occlusion shock.

Authors:  F Roviezzo; S Cuzzocrea; A Di Lorenzo; V Brancaleone; E Mazzon; R Di Paola; M Bucci; G Cirino
Journal:  Br J Pharmacol       Date:  2007-04-23       Impact factor: 8.739

10.  Sirtuin1-p53, forkhead box O3a, p38 and post-infarct cardiac remodeling in the spontaneously diabetic Goto-Kakizaki rat.

Authors:  Erik Vahtola; Marjut Louhelainen; Hanna Forstén; Saara Merasto; Johanna Raivio; Petri Kaheinen; Ville Kytö; Ilkka Tikkanen; Jouko Levijoki; Eero Mervaala
Journal:  Cardiovasc Diabetol       Date:  2010-01-27       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.